Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Secondhand Smoke
Interventions
DRUG

Nicotine polacrilex

Participants were given the choice of 2mg or 4mg lozenges depending on how many cigarettes per day they reported to smoke.

DRUG

Electronic Cigarette

Participants were given an e-cigarette starter kit, charging case, and cartridges in either 12mg or 16 mg nicotine, depending on their current amount of cigarettes smoked per day.

DRUG

Dissolvable Tobacco Lozenge

Participants were given Ariva (light to moderate smokers) or Stonewall (heavier smokers, \>2 packs per day).

Trial Locations (1)

73104

The Children's Hospital at OU Medical Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT01935713 - Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure | Biotech Hunter | Biotech Hunter